Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603746 · ClinicalTrials.gov registry record · Phase 2
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
A Phase 2 study of Asthma, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 627
- Enrollment target
- 20
- Study locations
NCT00603746 is a Phase 2 study of Asthma that has completed, run by GlaxoSmithKline. The registered enrollment target is 627 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (60% lower). The trial reports 20 study locations across 5 states.
The verdict
NCT00603746, a Phase 2 study of Asthma, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 627 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.
Conditions Studied
Interventions
- DRUG GW685698X
Study Locations (20)
California
- GSK Investigational Site - Fresno
- GSK Investigational Site - Granada Hills
- GSK Investigational Site - Huntington Beach
- GSK Investigational Site - Long Beach
- GSK Investigational Site - Long Beach
- GSK Investigational Site - Los Angeles
- GSK Investigational Site - Los Angeles
- GSK Investigational Site - Palmdale
- GSK Investigational Site - Riverside
- GSK Investigational Site - Roseville
- GSK Investigational Site - San Diego
- GSK Investigational Site - Torrance
- GSK Investigational Site - Walnut Creek
- GSK Investigational Site - West Covina
Arkansas
- GSK Investigational Site - Fort Smith
- GSK Investigational Site - Little Rock
Colorado
- GSK Investigational Site - Colorado Springs
- GSK Investigational Site - Wheat Ridge
Arizona
- GSK Investigational Site - Phoenix
Connecticut
- GSK Investigational Site - Bridgeport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 627 participants |
| Start Date | 2007-12-01 |
| Est. Completion | 2008-09-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00603746
The ClinicalTrials.gov registry entry for NCT00603746 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 627 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (60% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which GW685698X is the first listed.
NCT00603746 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Arkansas, Colorado.
Frequently Asked Questions
What is clinical trial NCT00603746 about?
NCT00603746 is a clinical study titled "A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.". This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.
What is the current status of trial NCT00603746?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 627 participants. The study started on 2007-12-01. Estimated completion is 2008-09-20.
What conditions does trial NCT00603746 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00603746?
The interventions under investigation include: GW685698X (DRUG).
Who is sponsoring clinical trial NCT00603746?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00603746 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.